West Virginia, Jackson County – The tragic drug related death of Teen Video Gamer, Christopher J. Rhodes, 19 has jumpstarted a revolution of change in the county. Christopher died last December of a drug overdose, since then Ace Gaming, a local gaming shop, began what is hoped will be an awareness campaign and an annual fundraiser. The goal is to combat the county’s rampant Teen drug problem.

The fundraising event will be something befitting of Christopher himself – a Video Game Tournament. The Event will be Held Saturday August 15th, 2009 for The Jackson County Anti-Drug Coalition…In honor of the Christopher J. Rhodes Memorial Foundation.

For More info visit: Ace Gaming Center – 235 Washington Street, Ravenwood, West Virginia 26164

                              Phone: 304 – 273 -0011

                              www.acewv.com

“When a child uses drugs, we assume that he/she is the only one who suffers. However, the family is suffering as much if not more, becuase they see their child in trouble and yet they are powerless to help them.” These are the words of a Former Crack Cocaine and Crystal Meth Addict located in florida, we’ll call him “Z”

When I used, I knew my family was feeling the pain to, but I didn’t care - I just wanted the high. As my addiction got more and more out of control, I started to notice the obviuos. I noticed my rapid weight Lost, bad breathe, Bad hygiene – Sometimes I’d forget to take showers for days.

I also started to notice that my family who became so fustrated with their failure to fix my addiction, that they began ressembling me. My Mother started loosing weight, started having nervous spells, couldn’t sleep, lost her apitite for life or anything else – she became addicted to wanting to help me/ fix my addiction. I mention my mother here, but my entire family – my sister, two brothers and even my farther started looking like addicts. As addicts we forget that the families also suffer, they serve the same sentence that we serve – our pain is their pain.

When I decided/court ordered to go into rehab, my family served that sentence with me as well – all three  times I relapsed. Now, it’s been almost 4 years since the last time I picked up. I have to say, the feeling of being clean is greater than any high I’ve ever exprienced. Since rehab “I am finally able to be a son to my parents, a brother to my siblings and a friend to all those who beleived and stood by me even when all hope seemed lost.”

Barbiturates were first introduced for medical use in the early 1900s. More than 2,500 barbiturates have been synthesized, and at the height of their popularity, about 50 were marketed for human use. Today, about a dozen are in medical use. Barbiturates produce a wide spectrum of central nervous system depression, from mild sedation to coma, and have been used as sedatives, hypnotics, anesthetics, and anticonvulsants. The primary differences among many of these products are how fast they produce an effect and how long those effects last. Barbiturates are classified as ultrashort, short, intermediate, and long-acting.

The ultrashort-acting barbiturates produce anesthesia within about one minute after intravenous administration. Those in current medical use are the Schedule IV drug methohexital (Brevital®), and the Schedule III drugs thiamyl (Surital®) and thiopental (Pentothal®). Barbiturate abusers prefer the Schedule II short-acting and intermediate-acting barbiturates that include amobarbital (Amyta®), pentobarbital (Nembutal®), secobarbital (Seconal®), and Tuinal (an amobarbital/secobarbital combination product). Other short and intermediate-acting barbiturates are in Schedule III and include butalbital (Fiorina®), butabarbital (Butisol®), talbutal (Lotusate®), and aprobarbital (Alurate®).

After oral administration, the onset of action is from 15 to 40 minutes, and the effects last up to six hours. These drugs are primarily used for insomnia and preoperative sedation. Veterinarians use pentobarbital for anesthesia and euthanasia. Long-acting barbiturates include phenobarbital (Luminal®) and mephobarbital (Mebaral®), both of which are in Schedule IV. Effects of these drugs are realized in about one hour and last for about 12 hours, and are used primarily for daytime sedation and the treatment of seizure disorders.